Low Grade Glioma — Trials

Low Grade Glioma — Trials · CancerIndex

Clinical trials

Registered studies

325 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04164901	Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)	active not recruiting	Phase 3	331	Institut de Recherches Internationales ServierOTHER	11	Apr 3, 2025	clinicaltrials
NCT05561374	Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma	active not recruiting	Phase 1	16	Oblato, Inc.INDUSTRY	1	Nov 29, 2024